[go: up one dir, main page]

BRPI0909205A2 - Complexos de rutênio como catalizadores para reações de metátese - Google Patents

Complexos de rutênio como catalizadores para reações de metátese

Info

Publication number
BRPI0909205A2
BRPI0909205A2 BRPI0909205-6A BRPI0909205A BRPI0909205A2 BR PI0909205 A2 BRPI0909205 A2 BR PI0909205A2 BR PI0909205 A BRPI0909205 A BR PI0909205A BR PI0909205 A2 BRPI0909205 A2 BR PI0909205A2
Authority
BR
Brazil
Prior art keywords
catalysts
metathesis reactions
ruthenium complexes
ruthenium
complexes
Prior art date
Application number
BRPI0909205-6A
Other languages
English (en)
Inventor
Kurt Puentener
Michelangelo Scalone
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0909205A2 publication Critical patent/BRPI0909205A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0909205-6A 2008-04-11 2009-03-30 Complexos de rutênio como catalizadores para reações de metátese BRPI0909205A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154367 2008-04-11
PCT/EP2009/053711 WO2009124853A1 (en) 2008-04-11 2009-03-30 New ruthenium complexes as catalysts for metathesis reactions

Publications (1)

Publication Number Publication Date
BRPI0909205A2 true BRPI0909205A2 (pt) 2015-08-11

Family

ID=40578497

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909205-6A BRPI0909205A2 (pt) 2008-04-11 2009-03-30 Complexos de rutênio como catalizadores para reações de metátese

Country Status (15)

Country Link
US (1) US7939668B2 (pt)
EP (1) EP2276725B1 (pt)
JP (1) JP5531008B2 (pt)
KR (1) KR101216900B1 (pt)
CN (1) CN101970396B (pt)
AU (1) AU2009235569B2 (pt)
BR (1) BRPI0909205A2 (pt)
CA (1) CA2719531C (pt)
DK (1) DK2276725T3 (pt)
ES (1) ES2388994T3 (pt)
IL (1) IL208034A (pt)
MX (1) MX2010010660A (pt)
PL (1) PL2276725T3 (pt)
SI (1) SI2276725T1 (pt)
WO (1) WO2009124853A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009142842A2 (en) 2008-04-15 2009-11-26 Intermune, Inc. Novel macrocyclic inhibitors of hepatitis c virus replication
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
WO2010127964A1 (en) * 2009-05-07 2010-11-11 F. Hoffmann-La Roche Ag Process for the preparation of ruthenium metathesis complex catalysts
WO2011079439A1 (en) * 2009-12-30 2011-07-07 Zannan Scitech Co., Ltd. Highly active metathesis catalysts selective for romp and rcm reactions
US8592618B2 (en) * 2010-01-08 2013-11-26 Zannan Scitech Co., Ltd. Highly active metathesis catalysts selective for ROMP and RCM reactions
WO2011119778A2 (en) 2010-03-24 2011-09-29 Yann Schrodi Method for in-situ formation of metathesis catalysts
US8633280B2 (en) * 2011-03-30 2014-01-21 Zannan Scitech Co., Ltd Methods of modifying polymers with highly active and selective metathesis catalysts
US9073801B2 (en) * 2011-06-03 2015-07-07 Massachusetts Institute Of Technology Z-selective ring-closing metathesis reactions
PL220408B1 (pl) * 2011-09-26 2015-10-30 Inst Chemii Organicznej Polskiej Akademii Nauk Kompleks rutentu, sposób jego wytwarzania oraz zastosowanie
WO2013137398A1 (ja) 2012-03-16 2013-09-19 日本ゼオン株式会社 開環メタセシス重合体水素化物の製造方法及び樹脂組成物
JP6092379B2 (ja) * 2012-06-29 2017-03-08 アペイロン シンセシス エス アー 金属錯体、その適用、及びメタセシス反応の実施方法
CN107233920A (zh) * 2016-03-29 2017-10-10 上海东杰高分子材料有限公司 一种钌络合物催化剂
CN106939026B (zh) * 2017-03-09 2020-03-20 上海克琴科技有限公司 一种钌金属烯烃复分解催化剂的制备及其应用
CN109280074A (zh) * 2017-07-20 2019-01-29 歌礼药业(浙江)有限公司 丹诺瑞韦钠晶体及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2811507A (en) * 1954-10-20 1957-10-29 Koppers Co Inc Alkenylaryloxyacetamides
US5936100A (en) * 1996-12-16 1999-08-10 Studiengesellschaft Kohle Mbh Synthesis of functionalized macrocycles by ring closing metathesis
EP0921129A1 (en) * 1997-12-03 1999-06-09 Studiengesellschaft Kohle mbH Highly active cationic ruthenium and osmium complexes for olefin metathesis reactions
EP1615949A1 (en) * 2003-04-10 2006-01-18 Boehringer Ingelheim International GmbH Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction
JP4733023B2 (ja) 2003-04-16 2011-07-27 ブリストル−マイヤーズ スクイブ カンパニー C型肝炎ウイルスの大環状イソキノリンペプチド阻害剤
DE10335416A1 (de) * 2003-08-02 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Metathesekatalysatoren
RS54573B1 (sr) 2003-10-14 2016-06-30 F. Hoffmann-La Roche Ltd Makrociklične karboksilne kiseline i acilsulfonamidi kao inhibitori replikacije hcv
US7491794B2 (en) 2003-10-14 2009-02-17 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
BRPI0509467A (pt) * 2004-03-30 2007-09-11 Intermune Inc compostos macrocìclicos como inibidores de replicação viral
EP1794179A1 (en) * 2004-09-17 2007-06-13 Boehringer Ingelheim International Gmbh Ring-closing metathesis process in supercritical fluid
GEP20105124B (en) 2005-07-25 2010-11-25 Array Biopharma Inc Novel macrocyclic inhibitors of hepatitis c virus replication
DE102006044699A1 (de) 2006-09-22 2008-04-03 Bayerische Motoren Werke Ag Tragrohr einer Instrumententafel eines Kraftfahrzeugs

Also Published As

Publication number Publication date
JP2011522778A (ja) 2011-08-04
US20090275714A1 (en) 2009-11-05
CN101970396A (zh) 2011-02-09
KR101216900B1 (ko) 2012-12-28
AU2009235569A1 (en) 2009-10-15
PL2276725T3 (pl) 2012-11-30
SI2276725T1 (sl) 2012-09-28
KR20100127822A (ko) 2010-12-06
AU2009235569B2 (en) 2012-03-29
CN101970396B (zh) 2014-06-18
MX2010010660A (es) 2010-10-25
CA2719531C (en) 2013-03-19
US7939668B2 (en) 2011-05-10
IL208034A0 (en) 2010-12-30
DK2276725T3 (da) 2012-08-20
ES2388994T3 (es) 2012-10-22
JP5531008B2 (ja) 2014-06-25
EP2276725B1 (en) 2012-07-04
WO2009124853A1 (en) 2009-10-15
CA2719531A1 (en) 2009-10-15
EP2276725A1 (en) 2011-01-26
IL208034A (en) 2014-09-30

Similar Documents

Publication Publication Date Title
BRPI0909205A2 (pt) Complexos de rutênio como catalizadores para reações de metátese
BRPI0906685A2 (pt) catalisadores para reações de metátese incluindo metátese de olefina enantiosseletiva, e métodos relacionados
PL2506972T3 (pl) Nośnikowe katalizatory metatezy olefin
PL2460587T3 (pl) Rutenowy układ katalityczny do reakcji metatezy olefin
BRPI0918782A2 (pt) catalisadores heterogêneos conformados
BRPI0918781A2 (pt) catalisadores heterogêneos conformados
BRPI0911542A2 (pt) compostos de quinuclina como ligantes de receptor de receptor de acetilcolina alfa-7-nicotínica
BRPI1014826A2 (pt) catalisadores de pirolise de atividade controlada
BRPI0917653A2 (pt) arranjo para um assento de veículo
BR112012005396A2 (pt) ferragem para um assento de veículo
GB0807607D0 (en) Catalyst
DK2406006T3 (da) Mobil denox-katalysator
BRPI0821766A2 (pt) Catalisador de ativação rápida
AP2010005415A0 (en) Catalysts.
GB0816709D0 (en) Shaped heterogeneneous catalysts
AP3177A (en) Catalysts
BRPI0810701A2 (pt) Catalisadores
BRPI1010555A2 (pt) microrreator de reação contínua.
BRPI0911432A2 (pt) método para a fabicação de complexos de carbeno rutênio
BRPI1007999A2 (pt) catalisador de reforma
BR112012010203A2 (pt) composição catalisadora apoiada
FI20086154A0 (fi) Katalyyttirakenne
GB0819847D0 (en) Cobalt catalysts
BR112013015481A2 (pt) catalisadores de hidrotratamento sustentados com titânia
PT2202201T (pt) Catalisadores de oxidação de amoníaco

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2508 DE 29-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.